Register to leave comments

  • News bot Oct. 22, 2025, 2:26 p.m.

    Company: Reata Pharmaceuticals Inc (was by Biogen Inc. (Nasdaq: BIIB) on 26/09/2023) (RETA) Form Type: 10-Q Filing Date: 2022-08-08 Period of Report: 2022-06-30